Elaine M Hylek

Elaine M Hylek

UNVERIFIED PROFILE

Are you Elaine M Hylek?   Register this Author

Register author
Elaine M Hylek

Elaine M Hylek

Publications by authors named "Elaine M Hylek"

Are you Elaine M Hylek?   Register this Author

100Publications

3519Reads

35Profile Views

Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment.

J Am Coll Cardiol 2019 Oct;74(14):1760-1768

Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Medicine, Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.07.070DOI Listing
October 2019

Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies.

Int J Cardiol 2019 07 8;286:198-207. Epub 2019 Feb 8.

Division of Cardiovascular Medicine, Cardio-Thoracic and Vascular Department, University of Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2019.02.004DOI Listing
July 2019

Oral Anticoagulants in Liver Disease: Not Child's Play.

J Am Coll Cardiol 2019 Jul;73(25):3309-3311

Division of Gastroenterology and Inborn Error Products, Center for Drug Evaluation and Research, Office of New Drugs/ODE III, U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.05.009DOI Listing
July 2019

Biomarkers for Prediction of Stroke and Bleeds in Atrial Fibrillation.

Authors:
Elaine M Hylek

Circulation 2019 02;139(6):772-774

Boston University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038635DOI Listing
February 2019

Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle.

Authors:
Elaine M Hylek

Thromb Haemost 2018 Dec 19;118(12):2018-2019. Epub 2018 Nov 19.

Department of Internal Medicine, Boston University, Boston, Massachusetts, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1676101DOI Listing
December 2018

Apixaban for End-Stage Kidney Disease.

Authors:
Elaine M Hylek

Circulation 2018 10;138(15):1534-1536

Boston University School of Medicine, MA.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.036449DOI Listing
October 2018

Anticoagulation reversal in vitamin K antagonist-associated intracerebral hemorrhage: a systematic review.

J Thromb Thrombolysis 2018 Aug;46(2):227-237

Section of Cardiology (DK), Section of General Internal Medicine (EMH), Department of Medicine, Boston Medical Center, Boston University School of Medicine, 88 East Newton Street, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-018-1667-5DOI Listing
August 2018

Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies.

Curr Pharm Des 2017 ;23(9):1406-1423

Johns Hopkins Hospital, Division of Cardiology, 1800 Orleans Street, Zayed 7125, Baltimore, MD 21287, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612822666161205110843DOI Listing
April 2018

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

J Am Heart Assoc 2018 01 26;7(3). Epub 2018 Jan 26.

Section of General Internal Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.117.007338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850242PMC
January 2018

Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).

Circ Arrhythm Electrophysiol 2017 Nov;10(11)

From the Duke Center for Atrial Fibrillation, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (A.S.B., S.K., L.E.T., E.D.P., J.P.P.); Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan-UCLA Medical Center (G.C.F.); Columbia University College of Physicians and Surgeons, New York, NY (J.A.R.); University of Colorado School of Medicine, Aurora (L.A.A.); Yale University School of Medicine, New Haven, CT (J.V.F.); Penn State Hershey Heart and Vascular Institute (G.N.); Stanford University School of Medicine, CA (K.W.M.); Kaiser Permanente Division of Research, Oakland, CA (A.S.G.); Lankenau Institute for Medical Research and Jefferson Medical College, Philadelphia, PA (P.R.K.); Hofstra Northwell School of Medicine, New York, NY (J.E.A.); Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN (B.J.G.); and Boston University Medical Center, MA (E.M.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCEP.117.005051DOI Listing
November 2017

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.

Clin Cardiol 2017 Sep 19;40(9):746-751. Epub 2017 May 19.

Cardiac Electrophysiology Section, Duke Center for Atrial Fibrillation, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/clc.22726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638096PMC
September 2017

Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.

J Am Coll Cardiol 2017 Sep;70(11):1325-1335

Department of Medicine, Division of Cardiology/Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, Los Angeles, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2017.07.755DOI Listing
September 2017

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.

N Engl J Med 2017 08 11;377(5):431-441. Epub 2017 Jul 11.

From Thomas Jefferson University, Philadelphia (C.V.P.); Boehringer Ingelheim, Ridgefield, CT (P.A.R., R.D., B.W.); Boehringer Ingelheim, Biberach (J.R., S.G., J.S.), Boehringer Ingelheim, Ingelheim am Rhein (J.K.), Klinikum Frankfurt Höchst, Frankfurt (T.S.), and Heidelberg University Hospital, Heidelberg (T.S.) - all in Germany; McMaster University and the Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada (J.W.E., J.I.W.); Feinberg School of Medicine, Northwestern University, Chicago (R.A.B.); Leiden University Medical Center, Leiden (M.V.H.), and Tergooi Hospital, Hilversum (P.W.K.) - both in the Netherlands; Boston University School of Medicine, Boston (E.M.H.); Tuen Mun Hospital, Hong Kong (C.-W.K.); Duke University School of Medicine, Durham, NC (J.H.L.); Middlemore Hospital (G.R.) and the University of Auckland (L.Y.) - both in Auckland, New Zealand; Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence (F.W.S.); and KU Leuven, Center for Molecular and Vascular Biology, Leuven, Belgium (P.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1707278DOI Listing
August 2017

Atrial fibrillation in women: treatment.

Nat Rev Cardiol 2017 02 27;14(2):113-124. Epub 2016 Oct 27.

Cardiac Arrhythmia Service and Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrcardio.2016.171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520636PMC
February 2017

Antithrombotic drug use: scientific breakthroughs, biological limits and physician behaviour.

Authors:
Elaine M Hylek

Heart 2016 12 8;102(23):1859-1860. Epub 2016 Aug 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2016-309902DOI Listing
December 2016

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.

Circulation 2016 Nov 28;134(22):1697-1707. Epub 2016 Aug 28.

From Department of Medical Sciences, Cardiology, Uppsala University, Sweden (J.O., Z.H., L.W.); Uppsala Clinical Research Center, Uppsala University, Sweden (J.O., Z.H., J.L., A.S., L.W.); Duke Clinical Research Institute, Duke Medicine, Durham, NC (J.H.A., C.B.G., R.D.L.); Population Health Research Institute, Hamilton, Canada (S.J.C., J.W.E., S.Y.); Thomas Jefferson Medical College and the Heart Center, Wynnewood, PA (M.D.E.); Boston University Medical Center, MA (E.M.H.); and Department of Medical Sciences, Clinical Chemistry, Uppsala University, Sweden (A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022802DOI Listing
November 2016

Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling.

Circulation 2016 10;134(15):1122-1124

From the Division of Cardiology, Duke University Medical Center, Durham, NC (S.D.P., J.P.P., E.D.P.); Duke Clinical Research Institute, Durham, NC (S.D.P., P.S., L.T., J.P.P., E.D.P.); Division of Cardiology, University of California Los Angeles (G.C.F.); Lankenau Institute for Medical Research, Wynnewood, PA (P.R.K.); Harvard Medical School, Massachusetts General Hospital, Boston (D.E.S.); Hofstra North Shore/Long Island School of Medicine, Hempstead, NY (J.A.); Mayo Clinic College of Medicine, Rochester, MN (BJ.G.); Department of Medicine, Stanford University School of Medicine, Palo Alto, CA (K.W.M.); Boston University School of Medicine, Boston, MA (E.M.H.); and Kaiser Permanente, Oakland, CA (A.S.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024333DOI Listing
October 2016

Atrial Fibrillation and Fall Risk: What Are the Treatment Implications?

J Am Coll Cardiol 2016 09;68(11):1179-1180

Department of General Medicine, Boston University School of Medicine, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2016.07.714DOI Listing
September 2016

Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy.

JAMA 2016 Aug;316(6):661-3

Division of Cardiology, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.9356DOI Listing
August 2016

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.

Lancet 2016 Jun 4;387(10035):2302-2311. Epub 2016 Apr 4.

Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)00741-8DOI Listing
June 2016

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.

Eur Heart J 2016 May 25;37(20):1582-90. Epub 2016 Feb 25.

Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden Uppsala Clinical Research Center, Uppsala University, Uppsala Science Park, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehw054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875560PMC
May 2016

Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.

Heart 2016 Apr 2;102(7):508-17. Epub 2016 Feb 2.

Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2015-308887DOI Listing
April 2016

Gender and tachycardia: independent modulation of platelet reactivity in patients with atrial fibrillation.

J Geriatr Cardiol 2016 Mar;13(3):202-8

Basil Hetzel Institute for Translational Research, Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11909/j.issn.1671-5411.2016.03.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826889PMC
March 2016

Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieu.

Herz 2016 Feb 2;41(1):57-62. Epub 2015 Jul 2.

Basil Hetzel Institute, Department of Cardiology, The Queen Elizabeth Hospital, University of Adelaide, Cardiology Unit, 28 Woodville Rd, Woodville South, 5011, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00059-015-4335-yDOI Listing
February 2016

Who, when, and how to reverse non-vitamin K oral anticoagulants.

J Thromb Thrombolysis 2016 Feb;41(2):253-72

Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston University, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-015-1297-0DOI Listing
February 2016

Paroxysmal atrial fibrillation and the hazards of under-treatment.

Int J Cardiol 2016 Jan 11;202:214-20. Epub 2015 Sep 11.

Department of Medicine, Boston Medical Center, Boston University, 801 Massachusetts Avenue, Crosstown 2, Boston, MA 02118 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2015.09.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527994PMC
January 2016

Trends in Warfarin Monitoring Practices Among New York Medicare Beneficiaries, 2006-2011.

J Community Health 2015 Oct;40(5):845-54

Healthcare Quality Improvement, IPRO, 20 Corporate Woods Boulevard, Albany, NY, 12211, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10900-015-0066-5DOI Listing
October 2015

Biomarkers in lone atrial fibrillation - an additional 'fine tuning' of risk?

Curr Pharm Des 2015 ;21(5):646-58

Boston Medical Center, 801 Massachusetts Avenue, 2nd floor suite, Boston, MA 02118.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612820666140825131744DOI Listing
August 2015

Idarucizumab for Dabigatran Reversal.

N Engl J Med 2015 Aug 22;373(6):511-20. Epub 2015 Jun 22.

From Pennsylvania Hospital, Philadelphia (C.V.P.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (P.A.R., R.D., B.W.); McMaster University (J.E., J.I.W.) and Thrombosis and Atherosclerosis Research Institute (J.I.W.) - both in Hamilton, ON, Canada; Boehringer Ingelheim Pharma, Biberach (S.G., J.S.) and Ingelheim (J.K.), Klinikum Frankfurt Höchst, Frankfurt am Main, and Heidelberg University Hospital, Heidelberg (T.S.) - all in Germany; University of Leuven, Leuven, Belgium (P.V.); Northwestern University, Chicago (R.A.B.); Leiden University Medical Center, Leiden (M.V.H.), and University Medical Center Groningen, Groningen, (P.W.K.) - both in the Netherlands; Boston University School of Medicine, Boston (E.M.H.); Duke University Medical Center, Durham, NC (J.H.L.); Brown Medical School and Rhode Island Hospital, Providence, RI (F.W.S.); and Tuen Mun Hospital, Tuen Mun, NT, Hong Kong (C.-W.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1502000DOI Listing
August 2015

Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin.

Thromb Haemost 2015 Jul 7;114(1):70-7. Epub 2015 May 7.

Eun-Jeong Kim, MD, Hospital Medicine Group, Division of General Internal Medicine, Massachusetts General Hospital, 55 Fruit Street Bulfinch 015, Boston, MA 02114, USA, Tel.: +1 617 724 3874, Fax: +1 617 643 1384, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH14-09-0754DOI Listing
July 2015

Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Circ Cardiovasc Qual Outcomes 2015 Jul 9;8(4):393-402. Epub 2015 Jun 9.

From the Yale University School of Medicine, New Haven, CT (J.V.F.); Duke Clinical Research Institute, Durham, NC (D.N.S., L.E.T., E.D.P., J.P.P.); Division of Research, Kaiser Permanente of Northern California, Oakland, CA (A.S.G.); Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (J.S.); Ronald Reagan-UCLA Medical Center, Los Angeles, CA (G.C.F.); Mayo Clinic Medical Center, Rochester, Minnesota (B.J.G.); Boston University Medical Center, Boston, MA (E.M.H.); Lankenau Institute for Medical Research and Jefferson Medical College, Philadelphia, PA (P.R.K.); and Stanford University School of Medicine, Stanford, CA (K.W.M.); Janssen Pharmaceuticals Inc., Bridgewater, NJ (P.C.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.114.001
Publisher Site
http://dx.doi.org/10.1161/CIRCOUTCOMES.114.001303DOI Listing
July 2015

Explaining racial disparities in anticoagulation control: results from a study of patients at the Veterans Administration.

Am J Med Qual 2015 May 18;30(3):214-22. Epub 2014 Mar 18.

Bedford VA Medical Center, Bedford, MA Boston University School of Medicine, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1062860614526282DOI Listing
May 2015

Left atrial appendage closure for stroke prevention in atrial fibrillation: response to an unmet need with an unclear direction.

Circ Arrhythm Electrophysiol 2015 Feb;8(1):8-10

From the Department of Medicine, Boston University School of Medicine, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCEP.115.002634DOI Listing
February 2015

Impaired platelet nitric oxide response in patients with new onset atrial fibrillation.

Int J Cardiol 2015 Jan 23;179:160-5. Epub 2014 Oct 23.

Basil Hetzel Institute, The Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2014.10.137DOI Listing
January 2015

Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation.

Circ Cardiovasc Qual Outcomes 2015 Jan 13;8(1):8-14. Epub 2015 Jan 13.

From the Department of Clinical and Administrative Sciences, Notre Dame of Maryland University School of Pharmacy, Baltimore (J.L.T.); Department of Neurology, University of Alabama at Birmingham (C.D., N.A.L.); Department of Medicine, Boston University Medical Center, MA (L.H., E.M.H.); Department of Biostatistics (Y.T.) and Date Coordinating Center (E.K.Q), Boston University School of Public Health, Boston, MA; and Department of Cardiology, Geisinger Health System, Danville, PA (K.B.F., P.B.B).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.113.000371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654947PMC
January 2015

Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.

Circulation 2014 Nov 7;130(21):1847-58. Epub 2014 Oct 7.

From the Department of Medical Sciences, Cardiology (L.W., Z.H.), Department of Medical Sciences, Cardiovascular Epidemiology (S.A.), and Department of Medical Sciences, Clinical Chemistry (A.S.), and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (L.W., Z.H.); Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (U.A.); Duke University, Medical Center, Durham, NC (J.H.A., R.D.L., C.B.G.); Gabriele d'Annunzio University, Chieti, and Gabriele Monasterio Foundation, Pisa, Italy (R.D.C.); Bristol-Myers Squibb, Princeton, NJ (M.H.); University of Adelaide, Adelaide, Australia (J.D.H.); and Boston University Medical Center, Boston, MA (E.M.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.011204DOI Listing
November 2014

Anticoagulation in the older adult: optimizing benefit and reducing risk.

Semin Thromb Hemost 2014 Sep 3;40(6):688-94. Epub 2014 Sep 3.

Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0034-1389083DOI Listing
September 2014

Age-related changes in thrombosis and hemostasis.

Semin Thromb Hemost 2014 Sep 26;40(6):619-20. Epub 2014 Sep 26.

Section of General Internal Medicine, Boston University School of Medicine, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0034-1390152DOI Listing
September 2014

Outcomes of anticoagulation therapy in patients with mental health conditions.

J Gen Intern Med 2014 Jun 19;29(6):855-61. Epub 2014 Feb 19.

Department of Community Based Clinics, University of Texas Medical Branch (UTMB), 6465 South Shore Blvd. Suite 500, League City, TX, 77573, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11606-014-2784-2
Publisher Site
http://dx.doi.org/10.1007/s11606-014-2784-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026501PMC
June 2014

Gaps in translation from trials to practice: non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation.

Thromb Haemost 2014 May 27;111(5):783-8. Epub 2014 Feb 27.

Elaine M. Hylek, MD, MPH, Boston University School of Medicine, Section of General Internal Medicine, 801 Massachusetts Avenue, 2nd fl suite, Boston, MA 02118, USA, Tel.: +1 617 414 3743, E-mail:

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1160/TH13-12-1032
Publisher Site
http://dx.doi.org/10.1160/TH13-12-1032DOI Listing
May 2014

Non-vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology.

Chest 2014 May;145(5):1177-1178

Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.13-2951DOI Listing
May 2014

Stratifying the risks of oral anticoagulation in patients with liver disease.

Circ Cardiovasc Qual Outcomes 2014 May 13;7(3):461-7. Epub 2014 May 13.

From the Center for Healthcare Organization and Implementation Research, Edith Nourse Rogers Memorial VA Medical Center, Bedford, MA (D.R.B., A.S.A., E.M.H., A.O., J.I.R., S.Z., G.K.J., A.J.R.); Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, MA (L.M.E., D.R.B., A.S.A., E.M.H., A.J.R.); Section of Gastroenterology, Granite Medical Group, Boston University Medical Center, MA (D.S.M.); Department of Health Policy and Management, Boston University School of Public Health, MA (D.R.B., G.K.J.); Division of Biostatistics and Health Services Research, Department of Quantitative Health Sciences, University of Massachusetts School of Medicine, Worcester (A.S.A.); and Biostatistics Section, Boston Children's Hospital, MA (A.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.113.000817DOI Listing
May 2014

National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation.

Circulation 2014 Apr 3;129(13):1407-14. Epub 2014 Feb 3.

Quest Diagnostics Nichols Institute, Chantilly, VA (J.S.D.); Quest Diagnostics, West Norriton, PA (R.A.G., X.H.); Quest Diagnostics, Madison, NJ (M.O., H.W.K.); Department of Medicine, Lenox Hill Hospital, New York, NY (J.A.); and Department of Medicine, Section of General Internal Medicine, Boston Medical Center, Boston, MA (E.M.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002601DOI Listing
April 2014

Comparing patient-level and site-level anticoagulation control as predictors of adverse events.

Thromb Res 2014 Apr 14;133(4):652-6. Epub 2014 Jan 14.

Center for Healthcare Organization and Implementation Research, Bedford VA Medical Center, Bedford, MA, United States; Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2014.01.013DOI Listing
April 2014

Warfarin interactions with antibiotics in the ambulatory care setting.

JAMA Intern Med 2014 Mar;174(3):409-16

Division of Hematology and Thromboembolism, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2013.13957DOI Listing
March 2014

The gender gap in academic leadership.

Authors:
Elaine M Hylek

Rev Clin Esp (Barc) 2014 Mar 7;214(2):83-4. Epub 2014 Feb 7.

Boston University School of Medicine, Boston, MA 02118, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rce.2014.01.013DOI Listing
March 2014